Eli Lilly is further expanding its RNA medicine strategy by tapping South Korea’s Rznomics for a $1.3 billion biobucks deal ...

Lilly will use Rznomics’ proprietary ribozyme technology to develop RNA editing therapies for congenital hearing loss.

Adam Kovalčík figured out how to make an antiviral drug for a fraction of the normal cost, using an alcohol from corn husks.

The deal gives Lilly access to the company’s RNA-editing platform to develop therapies for sensorineural hearing loss.

An international research team has discovered a critical protein that acts as a 'switch' regulating immune responses to viruses.

Kids to Love is partnering with iXpressGenes (iXG) in kickstarting a new clinical trial aimed at addressing PTSD through ...

Every living creature on Earth needs to protect itself from things that would do it harm. Bacteria are no different. And ...

Dementia usually impacts older people, and it can be hard to recognize in middle age. Notably, frontotemporal dementia is ...

A combination shot for flu and Covid-19 using messenger RNA generated antibodies in a study, but US government regulators ...

A study reveals that inflammation associated with Marfan syndrome increases vulnerability to neurological diseases and complications following strokes, as demonstrated in animal models.

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with rising incidence linked to ...

Following after is P-500, a selective, brain-penetrant PRMT5 inhibitor for advanced solid tumours, including high-grade ...